Literature DB >> 21299784

Socioeconomic deprivation, readmissions, mortality and acute exacerbations of bronchiectasis.

M E Roberts1, L Lowndes, D G Milne, C A Wong.   

Abstract

BACKGROUND: Bronchiectasis is known to cause significant morbidity in children in New Zealand. Little is known of the disease in adults. AIM: Our objective was to characterise a cohort of adults who presented to hospital with acute exacerbations of the disease.
METHODS: We retrospectively collected information on all exacerbations treated as inpatients from a single hospital in South Auckland, New Zealand during 2002.
RESULTS: We collected information on 307 exacerbations in 152 patients. Twenty-seven per cent were of Maaori ethnic origin, and 44% Pacific. Seventy per cent lived in areas categorised as the 20% most deprived in New Zealand. Comorbid conditions were present in 80% of patients - most commonly chronic obstructive pulmonary disease, asthma, diabetes and cardiac disease. Seventy (46%) patients had at least one readmission and 32 patients (21%) died within 12 months of admission to hospital. Greater deprivation was associated with increased mortality at 12 months after admission after adjusting for other factors (OR 11, 95% CI 2.0-61, P= 0.006). In the subgroup who underwent high-resolution computed tomographic scanning (93), increasing severity of bronchiectasis (modified Bhalla score) was associated with readmission within 12 months (P= 0.004), but not mortality (P= 0.419).
CONCLUSIONS: We have shown that exacerbations of bronchiectasis in South Auckland are more common in patients who are predominantly of Maaori or Pacific descent and are socioeconomically deprived. Admission to hospital for an exacerbation is associated with high readmission and mortality rates.
© 2011 The Authors. Internal Medicine Journal © 2011 Royal Australasian College of Physicians.

Entities:  

Mesh:

Year:  2012        PMID: 21299784     DOI: 10.1111/j.1445-5994.2011.02444.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  14 in total

1.  Respiratory exacerbations in indigenous children from two countries with non-cystic fibrosis chronic suppurative lung disease/bronchiectasis.

Authors:  Gregory J Redding; Rosalyn J Singleton; Patricia C Valery; Hayley Williams; Keith Grimwood; Peter S Morris; Paul J Torzillo; Gabrielle B McCallum; Lori Chikoyak; Robert C Holman; Anne B Chang
Journal:  Chest       Date:  2014-09       Impact factor: 9.410

2.  Could vitamin d have a potential anti-inflammatory and anti-infective role in bronchiectasis?

Authors:  Jim Bartley; Jeff Garrett; Cameron C Grant; Carlos A Camargo
Journal:  Curr Infect Dis Rep       Date:  2013-04       Impact factor: 3.725

3.  Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation.

Authors:  Michael M Tunney; Gisli G Einarsson; Lan Wei; Maire Drain; Erich R Klem; Chris Cardwell; Madeleine Ennis; Richard C Boucher; Matthew C Wolfgang; J Stuart Elborn
Journal:  Am J Respir Crit Care Med       Date:  2013-05-15       Impact factor: 21.405

4.  Impact of socio-economic status on hospital length of stay following injury: a multicenter cohort study.

Authors:  Lynne Moore; Brahim Cisse; Brice Lionel Batomen Kuimi; Henry T Stelfox; Alexis F Turgeon; François Lauzier; Julien Clément; Gilles Bourgeois
Journal:  BMC Health Serv Res       Date:  2015-07-25       Impact factor: 2.655

5.  Differences of lung microbiome in patients with clinically stable and exacerbated bronchiectasis.

Authors:  Min Kwang Byun; Joon Chang; Hyung Jung Kim; Seok Hoon Jeong
Journal:  PLoS One       Date:  2017-08-22       Impact factor: 3.240

6.  Sex bias in diagnostic delay in bronchiectasis: An analysis of the Spanish Historical Registry of Bronchiectasis.

Authors:  Rosa Ma Girón; Javier de Gracia Roldán; Casilda Olveira; Montserrat Vendrell; Miguel Ángel Martínez-García; David de la Rosa; Luis Máiz; Julio Ancochea; Liliana Vázquez; Luis Borderías; Eva Polverino; Eva Martínez-Moragón; Olga Rajas; Joan B Soriano
Journal:  Chron Respir Dis       Date:  2017-04-10       Impact factor: 2.444

7.  Patients hospitalized with an infective exacerbation of bronchiectasis unrelated to cystic fibrosis: Clinical, physiological and sputum characteristics.

Authors:  Victoria Venning; James Bartlett; Lata Jayaram
Journal:  Respirology       Date:  2017-02-24       Impact factor: 6.424

8.  The Roles of Bacteria and Viruses in Bronchiectasis Exacerbation: A Prospective Study.

Authors:  Chun-Lan Chen; Yan Huang; Jing-Jing Yuan; Hui-Min Li; Xiao-Rong Han; Miguel Angel Martinez-Garcia; David de la Rosa-Carrillo; Rong-Chang Chen; Wei-Jie Guan; Nan-Shan Zhong
Journal:  Arch Bronconeumol (Engl Ed)       Date:  2020-04-08       Impact factor: 4.872

Review 9.  Bronchiectasis in the Last Five Years: New Developments.

Authors:  Jun Keng Khoo; Victoria Venning; Conroy Wong; Lata Jayaram
Journal:  J Clin Med       Date:  2016-12-08       Impact factor: 4.241

10.  Prospective community programme versus parent-driven care to prevent respiratory morbidity in children following hospitalisation with severe bronchiolitis or pneumonia.

Authors:  Catherine Ann Byrnes; Adrian Trenholme; Shirley Lawrence; Harley Aish; Julie Anne Higham; Karen Hoare; Aileen Elborough; Charissa McBride; Lyndsay Le Comte; Christine McIntosh; Florina Chan Mow; Mirjana Jaksic; Russell Metcalfe; Christin Coomarasamy; William Leung; Alison Vogel; Teuila Percival; Henare Mason; Joanna Stewart
Journal:  Thorax       Date:  2020-02-24       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.